Central nervous system (CNS) stimulant drugs are those substances which speed up the physical and mental processes in the body. Stimulants have a chemical structure similar to monoamine neurotransmitters. These drugs are used in various medical conditions. Stimulants have numerous mechanism of actions. Most commonly, the stimulant drugs increase the level of a neurotransmitter known as dopamine, which stimulates the brain activity. CNS stimulants drugs are used for narcolepsy, neonatal apnea, lethargy, and others. These stimulants are primarily used as prescribed drugs but often are used without prescriptions or illegally for recreational use.
The global central nervous system stimulant drugs market is expected to expand at a significant CAGR during the forecast period. Rise in central nervous system disorders, sleeping disorders, and asthma are some of the major factors driving the growth of the market during the forecast period. According to a study conducted by the American Academy of Sleep Medicine in 2016, it was estimated that there is a six-fold increase in the prevalence of sleep disorders in the U.S., which is likely to propel the growth of the global market during the forecast period. Surge in mood disorders and post-traumatic stress are further responsible for driving the market growth. In addition, the illegal drug market is booming owing to increase in the production of stimulants such as cocaine and heroin and rise in drug trafficking. Numerous side effects of drugs such as tachycardia and anxiety and increase in the usage for recreational purpose and doping are the significant factors which can restrain the market growth.
The global central nervous system stimulant drugs market can be segmented on the basis of type, application, end-user, and region. On the basis of type, the global market can be segmented into amphetamine, caffeine, nicotine, methamphetamine, and others. The methamphetamine segment is anticipated to account for a significant share of the global CNS stimulant drugs market during the forecast period due to its widespread use in the treatment of attention deficit hyperactivity disorders (ADHD). On the basis of application, the market can be divided into ADHD, sleeping disorder, depression, obesity, respiratory depression, and others. The depression segment is expected to hold a significant share of the global market during the forecast period owing to increase in the prevalence of depression among adults and children worldwide.
The global CNS stimulant drugs market is projected to expand at a steady growth rate across regions. Geographically, the global market is distributed over North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is anticipated to dominate the global CNS stimulant drugs market in terms of value and volume in the near future. The factors attributing to the growth of the market in North America are the prevalence of unhealthy lifestyle habits and rise in depression and drug abuse. North America is closely followed by Europe. Increase in the cultivation of coca bush in 2015 due to rise in the demand for drugs in Europe propelled the market growth in the region. Asia Pacific is expected to expand at a high growth rate during the forecast period due to increase in the demand for drugs for the treatment of ADHD and depression and surge in drug trafficking in the region.
Prominent players operating in the global central nervous system stimulant drugs market are Pfizer Inc., Teva Pharmaceuticals USA, Inc., and Novartis.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.